Thanks mita. That article seems to be appearing in a few publications. While they were wrong about the details of the deal with Actavis they are right about the rest.
Sentiment is changing and there's a realization (supported with broker updates) the sp is too low given the opportunity. We just needed the resubmission to lock in the timelines to give the brokers something to work with. Everyone likes time frames.
I think we are in the middle of the same rerating that took us to 125c in January and was interrupted by the announcement the resubmission was expected in Q1. The market didn't like the (resubmission time line) uncertainty and positions were unwound bringing the sp back to 100c. Don't expect that to happen again. 100c is gone. Opportunity missed.
This can go back to pre CRL approval prices.
QRX Price at posting:
$1.32 Sentiment: Buy Disclosure: Held